Nephros, Inc. (NEPH)
4.90
+0.02
(+0.41%)
USD |
NASDAQ |
Jan 02, 12:41
Nephros Research and Development Expense (TTM): 1.196M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Apyx Medical Corp. | 3.546M |
| Owlet, Inc. | 12.94M |
| Perspective Therapeutics, Inc. | 61.22M |
| Xtant Medical Holdings, Inc. | 2.165M |
| VolitionRX Ltd. | 9.144M |